Contaminated Blood and Blood Products

Debate between Tom Clarke and Diane Abbott

Thursday 14th October 2010 Commons Chamber

[Mr Clarke]

Indeed, a lot of people in the Haemophilia Society and other supporters of my hon. Friend the Member for Coventry North West are genuinely looking forward to what the Under-Secretary of State for Health, the hon. Member for Guildford (Anne Milton) is going to offer them before Christmas.

That said, I want to go on to talk about one of my constituents, with whom I had a discussion yesterday. The House has to accept its responsibilities on these matters, including its responsibilities for delay after delay, even though evidence has been available. We have not given a response to the people who are suffering very gravely. We are talking about a number of people dying, families bereft of their members and the impact of not having acted previously. There is the issue of not having proper regard to the blood we are using. Then there is the use of American blood from we know not where, and now the decision taken not to use UK blood because we think there might be an element leading to new variant CJD. Frankly, a degree of incompetence is evident, which people interested in our debate will find hugely unacceptable.

[Ms Diane Abbott (Hackney North and Stoke Newington) (Lab)]

My right hon. Friend talked about American blood from we know not where. The tragedy is that we do know where much of it came from. It was from paid donors, many of whom were prisoners and drug addicts, leading to consequences about which we all now know.

[Mr Clarke]

I am grateful for my hon. Friend’s intervention.

The kind of information that we have—and we have had interventions year after year—in terms of giving us the facts and the evidence, quite apart from what our constituents are drawing to our attention, was embraced in Lord Archer’s report, to which the motion refers. That report, which I very much welcome, led to Lord Morris of Manchester—both our noble Friends have done a commendable job in bringing these issues to our attention—attempting to deal with the problem through legislation. A Bill came to this House at the beginning of this year, but where did it go? Nowhere.

That brings me to what this issue means for our constituents. I spoke yesterday to a man in my constituency—I will not name him—who is now 36. He described the bizarre experiences of his case. He talked about the secrecy surrounding these matters. The excellent Yorkhill hospital in Glasgow has a very good reputation, but a large number of papers pertaining to it have simply gone missing. My constituent talked about the stigma of having hepatitis C; he had been told for many years that he did not have hepatitis A or B, and was lucky not to have AIDS. His doctor withheld information on his particular case for more than a year. He told me only yesterday what the real problems were—for example, the difficulty of getting life insurance and a mortgage for himself and his partner.